was read the article
array:23 [ "pii" => "S2529993X17301119" "issn" => "2529993X" "doi" => "10.1016/j.eimce.2017.03.020" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "1507" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2017;35:293-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 362 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 216 "PDF" => 139 ] ] "itemSiguiente" => array:19 [ "pii" => "S2529993X17301004" "issn" => "2529993X" "doi" => "10.1016/j.eimce.2017.03.009" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "1559" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Enferm Infecc Microbiol Clin. 2017;35:299-302" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 932 "formatos" => array:3 [ "EPUB" => 6 "HTML" => 680 "PDF" => 246 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Brief report</span>" "titulo" => "To whom is HIV pre-exposure prophylaxis proposed?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "299" "paginaFinal" => "302" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "¿A quién proponer la profilaxis preexposición al virus de la inmunodeficiencia humana?" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1182 "Ancho" => 2360 "Tamanyo" => 151871 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Socio-demographic, behavioural and clinical characteristics of recent HIV seroconverters.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Oskar Ayerdi-Aguirrebengoa, Mar Vera-García, Teresa Puerta-López, Montserrat Raposo-Utrilla, Carmen Rodríguez-Martín, Jorge Del Romero-Guerrero" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Oskar" "apellidos" => "Ayerdi-Aguirrebengoa" ] 1 => array:2 [ "nombre" => "Mar" "apellidos" => "Vera-García" ] 2 => array:2 [ "nombre" => "Teresa" "apellidos" => "Puerta-López" ] 3 => array:2 [ "nombre" => "Montserrat" "apellidos" => "Raposo-Utrilla" ] 4 => array:2 [ "nombre" => "Carmen" "apellidos" => "Rodríguez-Martín" ] 5 => array:2 [ "nombre" => "Jorge" "apellidos" => "Del Romero-Guerrero" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213005X16301525" "doi" => "10.1016/j.eimc.2016.06.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X16301525?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X17301004?idApp=UINPBA00004N" "url" => "/2529993X/0000003500000005/v1_201705111055/S2529993X17301004/v1_201705111055/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2529993X17300990" "issn" => "2529993X" "doi" => "10.1016/j.eimce.2017.03.008" "estado" => "S300" "fechaPublicacion" => "2017-05-01" "aid" => "1491" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2017;35:287-92" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 783 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 621 "PDF" => 155 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Community-acquired febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in hospitalised infants" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "287" "paginaFinal" => "292" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Infección urinaria febril adquirida en la comunidad por bacterias productoras de betalactamasas de espectro extendido en niños hospitalizados" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 986 "Ancho" => 1733 "Tamanyo" => 93616 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Design of the case–control study from 2005 to 2014.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Roberto Hernández Marco, Elena Guillén Olmos, José Rafael Bretón-Martínez, Lourdes Giner Pérez, Benedicta Casado Sánchez, Julia Fujkova, Marina Salamanca Campos, José Miguel Nogueira Coito" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Roberto" "apellidos" => "Hernández Marco" ] 1 => array:2 [ "nombre" => "Elena" "apellidos" => "Guillén Olmos" ] 2 => array:2 [ "nombre" => "José Rafael" "apellidos" => "Bretón-Martínez" ] 3 => array:2 [ "nombre" => "Lourdes" "apellidos" => "Giner Pérez" ] 4 => array:2 [ "nombre" => "Benedicta" "apellidos" => "Casado Sánchez" ] 5 => array:2 [ "nombre" => "Julia" "apellidos" => "Fujkova" ] 6 => array:2 [ "nombre" => "Marina" "apellidos" => "Salamanca Campos" ] 7 => array:2 [ "nombre" => "José Miguel" "apellidos" => "Nogueira Coito" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0213005X16000720" "doi" => "10.1016/j.eimc.2016.01.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X16000720?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X17300990?idApp=UINPBA00004N" "url" => "/2529993X/0000003500000005/v1_201705111055/S2529993X17300990/v1_201705111055/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Evolution of antibiotic multiresistance in <span class="elsevierStyleItalic">Escherichia coli</span> and <span class="elsevierStyleItalic">Klebsiella pneumoniae</span> isolates from urinary tract infections: A 12-year analysis (2003–2014)" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "293" "paginaFinal" => "298" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "David M. Arana, Margarita Rubio, Juan-Ignacio Alós" "autores" => array:3 [ 0 => array:3 [ "nombre" => "David M." "apellidos" => "Arana" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Margarita" "apellidos" => "Rubio" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:4 [ "nombre" => "Juan-Ignacio" "apellidos" => "Alós" "email" => array:1 [ 0 => "nachoalos@telefonica.net" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Microbiología, Hospital Universitario de Getafe, Getafe, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Facultad de Ciencias Biomédicas, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Evolución de la multirresistencia a los antibióticos en <span class="elsevierStyleItalic">Escherichia coli</span> y <span class="elsevierStyleItalic">Klebsiella pneumoniae</span> aislados de infecciones del tracto urinario. Un análisis de 12 años (2003-2014)" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1682 "Ancho" => 2792 "Tamanyo" => 336619 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Prevalence and evolution of <span class="elsevierStyleItalic">E. coli</span> (A) and <span class="elsevierStyleItalic">K. pneumoniae</span> (B) urinary isolates from both, community and hospitalized patients, in individual resistance to amoxicillin, ciprofloxacin, gentamicin and trimethoprim–sulphamethoxazole.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The increasing rate of antibiotic resistance in uropathogens, especially in <span class="elsevierStyleItalic">Escherichia coli</span> and <span class="elsevierStyleItalic">Klebsiella pneumoniae</span>, as the most common etiologic agents of urinary tract infections (UTI), leads to difficulties in choosing adequate empirical therapy and achieving treatment success.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Multiple studies regarding antibiotic susceptibility in uropathogens have been published in medical literature,<a class="elsevierStyleCrossRefs" href="#bib0155"><span class="elsevierStyleSup">1–4</span></a> but only a few studies have addressed the multidrug resistance (MDR) behaviour.<a class="elsevierStyleCrossRefs" href="#bib0175"><span class="elsevierStyleSup">5–7</span></a> According to a group of international experts from European Centre for Disease Prevention (ECDC) and Centers for Disease Control and Prevention (CDC) a standardized international definition for MDR was created. MDR is defined as acquired non-susceptibility to at least one agent in three or more antimicrobial categories.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">8</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">MDR bacteria are more usually associated with nosocomial infections. A significant part of nosocomial infections are diagnosed as UTI (more than 30%) and a considerable part of the antimicrobial agents used in hospitals is dedicated for their treatment.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">9</span></a> However, the vast majority of UTI come from outpatients, the most common being uncomplicated cystitis (infection of bladder) in women. The 2010 guidelines of the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases recommend for empirical treatment of acute uncomplicated cystitis trimethoprim–sulphamethoxazole (if the local resistance is less than 20%), nitrofurantoin, fosfomycin trometamol and pivmecillinam (as first-line therapy). Fluoroquinolones may be used only as alternative therapy and their use must be avoided to treat uncomplicated cystitis whenever possible.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">10</span></a> MDR bacteria at the community level has increased, making the treatment of infections more difficult and requiring, in some cases, intravenous therapy because of the lack of oral options.<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">11</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Several factors contribute to the increasing spread of MDR to antimicrobials. The overuse and misuse of antimicrobials inhuman medicine, in veterinary and in agriculture represent, among others, are some of the main factors involved in the selective pressure.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In addition, MDR in urine isolates from the community is often associated with the presence of multiple extended-spectrum-β-lactamases (ESBL) genes, as well as aminoglycoside and quinolone resistance genes.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">12</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">This study aims to identify MDR in the main enterobacteriaceae implicated as etiologic agents in UTI (<span class="elsevierStyleItalic">E. coli</span> and <span class="elsevierStyleItalic">K. pneumoniae</span>) from both, community and hospitalized patients, and to analyze the evolution over a 12-year period.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Study population and bacterial isolates</span><p id="par0035" class="elsevierStylePara elsevierViewall">A 12-year (2003–2014) retrospective study was conducted in both hospitalized and non-hospitalized patients suspected of UTI at the Hospital Universitario de Getafe (Madrid). The hospital has 413–600 operational beds and an attended population of 211,000–260,000 inhabitants (depending on the year). During the period of the study, each urine sample was cultured using a 1<span class="elsevierStyleHsp" style=""></span>μL calibrated loop in cysteine lactose electrolytes deficient (CLED) agar and incubated at 37<span class="elsevierStyleHsp" style=""></span>°C for 18–24<span class="elsevierStyleHsp" style=""></span>h. A growth of >10<span class="elsevierStyleSup">4</span> colony-forming units (CFU) per mL of one type of organism were considered as a positive result. Identification and antibiotic susceptibilities were performed using a microdilution system (WIDER, Franscico Soria Melguizo, SA).</p><p id="par0040" class="elsevierStylePara elsevierViewall">Microb Dynamic software (Francisco SoriaMelguizo, SA) was used to analyze the microbiology laboratory database. It provides analysis of antimicrobial susceptibility and resistance test results according to the European Committee for Antimicrobial Susceptibility Testing (EUCAST) 2015 (version 5.0) clinical breakpoints (<a href="http://www.eucast.org/">www.eucast.org</a>). The software was used to determine the prevalence of both MDR <span class="elsevierStyleItalic">E. coli</span> and <span class="elsevierStyleItalic">K. pneumoniae</span>. In order to avoid distortions in the final results, isolates from the same patient with different antibiotic susceptibility patterns were considered as different while isolates showing the same pattern were considered as unique.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Statistical analysis</span><p id="par0045" class="elsevierStylePara elsevierViewall">A chi square test was applied to compare differences in group proportions in three different periods: 2003–2006, 2007–2010 and 2011–2014. Chi square test for trend was used to determine whether there was a statistically significant linear trend over the period of the study. A <span class="elsevierStyleItalic">p</span>-value <0.05 was considered as statistically significant. All statistical analyses were performed using Epi Info v. 7 (CDC, Atlanta, USA).</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Antimicrobial susceptibility</span><p id="par0050" class="elsevierStylePara elsevierViewall">We determined the proportion of isolates resistant to at least the antimicrobials agents that we chose as MDR markers (amoxicillin, gentamicin, ciprofloxacin and trimethoprim–sulphamethoxazole) according to their clinical antimicrobial MIC breakpoints: amoxicillin (MIC >8<span class="elsevierStyleHsp" style=""></span>mg/L), ciprofloxacin (MIC >1<span class="elsevierStyleHsp" style=""></span>mg/L), trimethoprim–sulphamethoxazole (MIC >4/76<span class="elsevierStyleHsp" style=""></span>mg/L) and gentamicin (MIC >4<span class="elsevierStyleHsp" style=""></span>mg/L). Amoxicillin is not considered in <span class="elsevierStyleItalic">K. pneumoniae</span> because of its intrinsic resistance. We also determined the global prevalence of ESBL producing <span class="elsevierStyleItalic">E. coli</span> and <span class="elsevierStyleItalic">K. pneumoniae</span> (MDR and non-MDR) and the proportion of both, MDR <span class="elsevierStyleItalic">E. coli</span> and MDR <span class="elsevierStyleItalic">K. pneumoniae</span> isolates harbouring ESBL. Positive results derived from ESBL producing enterobacteriaceae isolates are routinely introduced in the database when phenotypic studies are developed in the suspected ESBL producers.</p></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Results</span><p id="par0055" class="elsevierStylePara elsevierViewall">In total, the laboratory counted 39,980 positive urine samples over the 12-year period. 34,564 positive urine samples (3786 from hospitalized patients and 30,778 from non-hospitalized patients) had <span class="elsevierStyleItalic">E. coli</span> as the infecting organism and 5,422 positive urine cultures (774 from hospitalized patients and 4,648 from non-hospitalized patients) had <span class="elsevierStyleItalic">K. pneumoniae</span> as the etiological organism.</p><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Prevalence and evolution of MDR profiles</span><p id="par0060" class="elsevierStylePara elsevierViewall">The prevalence of UTI due to MDR <span class="elsevierStyleItalic">E. coli</span> (resistance at least to amoxicillin, ciprofloxacin, gentamicin and trimethoprim–sulphamethoxazole) in hospitalized patients increased from 5.89% [70 out of 1,188 isolates] in the period 2007–2010 to 8.18% [79 out of 966 isolates] in the period 2011–2014 (1.4-fold increase) (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.038). Similar results were observed in the same period when outpatient population was analyzed: 3.13% [332 out of 10,615 isolates] <span class="elsevierStyleItalic">versus</span> 4.58% [456 out of 9,947 isolates], respectively (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001). No significant differences were observed between the first and the second periods of the study (2003–2006 and 2007–2010) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0065" class="elsevierStylePara elsevierViewall">However, the prevalence of UTI caused by MDR <span class="elsevierStyleItalic">K. pneumoniae</span> (resistance at least to ciprofloxacin, gentamicin and trimethoprim–sulphamethoxazole) suffered a more drastic change between 2007–2010 and 2011–2014. <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B shows a 4-fold increase in hospitalized patients (2.38% [6 out of 252 isolates] in 2007–2010 <span class="elsevierStyleItalic">versus</span> 9.35% [23 out of 246 isolates] in 2011–2014; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001). This change in prevalence was even more pronounced (8-fold increase) when outpatient population was analyzed (0.47% [8 out of 1,689 isolates] in 2007–2010 <span class="elsevierStyleItalic">versus</span> 3.78% [67 out of 1,774 isolates] in 2011–2014; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001) A slight but not significant increase was also observed between the first and second periods (2003–2006 <span class="elsevierStyleItalic">versus</span> 2007–2010) in both hospitalized and non-hospitalized patients (1.45% [4 out of 276 isolates] <span class="elsevierStyleItalic">versus</span> 2.38% [6 out of 252 isolates] and 0.08% [1 out of 1,185 isolates] <span class="elsevierStyleItalic">versus</span> 0.47% [8 out of 1,689 isolates] respectively) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B).</p><p id="par0070" class="elsevierStylePara elsevierViewall">Therefore, higher percentages of MDR <span class="elsevierStyleItalic">E. coli</span> in hospitalized patients with respect to outpatients (1.8-fold increase in all the time periods) were evident and maintained constant over time (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A). Similar results were observed in the percentage of MDR <span class="elsevierStyleItalic">K. pneumoniae</span> isolates, but the differences with respect to the non-hospitalized patients were more marked (>1.8-fold increase in all the time periods) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>B). It is important to note that the increase observed in the prevalence of MDR <span class="elsevierStyleItalic">E. coli</span> isolates is mainly due to the individual resistance to ciprofloxacin and gentamicin regardless of the patient hospitalization, while individual resistance to amoxicillin and trimethoprim–sulphamethoxazole remained stable during the period of the study (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>A).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">By contrast, the increase in prevalence of MDR <span class="elsevierStyleItalic">K. pneumoniae</span> isolates is due to the individual resistance to ciprofloxacin, gentamicin and trimethoprim–sulphamethoxazole (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>B).</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">ESBL contribution to the MDR profile</span><p id="par0080" class="elsevierStylePara elsevierViewall">The global prevalence of UTI due to ESBL producing <span class="elsevierStyleItalic">E. coli</span> in hospitalized patients increased from 8.1% in the period 2003–2006 to 10.3% in the period 2011–2014 (1.27 fold-increase) while this increase in prevalence was more marked when non-hospitalized patients were analyzed (2.7% in 2003–2006 <span class="elsevierStyleItalic">versus</span> 5.7% in 2011–2014; 2 fold-increase).</p><p id="par0085" class="elsevierStylePara elsevierViewall">However, the rise in global prevalence of UTI due to ESBL producing <span class="elsevierStyleItalic">K. pneumoniae</span> in both, hospitalized and outpatients was more pronounced (6.1% in 2003–2006 <span class="elsevierStyleItalic">versus</span> 15% in 2011–2014; 2.4 fold-increase and 1.1% in 2003–2006 <span class="elsevierStyleItalic">versus</span> 5.5% in 2011–2014; 5 fold-increase, respectively). <a class="elsevierStyleCrossRefs" href="#tbl0005">Table 1</a> show an analysis for linear trend in ESBL-producing <span class="elsevierStyleItalic">E. coli</span> and ESBL-producing <span class="elsevierStyleItalic">K. pneumoniae</span> in hospitalized patients (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1A</a>) and non-hospitalized patients (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 1B</a>) over the period of the study.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">In order to determine the contribution of ESBL in the MDR phenotype of both <span class="elsevierStyleItalic">K. pneumoniae</span> and <span class="elsevierStyleItalic">E. coli</span>, Microb Dynamic software was used to analyze the percentage of MDR isolates harbouring an ESBL.</p><p id="par0095" class="elsevierStylePara elsevierViewall">The results show that the prevalence of UTI due to ESBL producing MDR <span class="elsevierStyleItalic">E. coli</span> in hospitalized patients increased from 0.86% in the period 2003–2006 to 3.11% in the period 2011–2014 (3.6 fold-increase) while this increase in prevalence was more marked, as above, when non-hospitalized patients were analyzed (0.18% in 2003–2006 <span class="elsevierStyleItalic">versus</span> 1.08% in 2011–2014; 6 fold-increase).</p><p id="par0100" class="elsevierStylePara elsevierViewall">By contrast, the prevalence of UTI due to ESBL producing MDR <span class="elsevierStyleItalic">K. pneumoniae</span> in hospitalized patients increased from 1.09% in the period 2003–2006 to 7.72% in the period 2011–2014 (7.6 fold-increase) while this increase in prevalence was more marked when non-hospitalized patients were analyzed (0.08% in 2003–2006 <span class="elsevierStyleItalic">versus</span> 2.82% in 2011–2014; 35.2 fold-increase). In hospitalized patients, 14 out of 70 (20%) MDR <span class="elsevierStyleItalic">E. coli</span> isolates were MDR ESBL-producing <span class="elsevierStyleItalic">E. coli</span> in 2007–2010. This percentage increased to 38% (30 out of 79) in 2011–2014 (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.016). However, the increase observed in non-hospitalized patients between the same periods was not as marked (18.2% in 2007–2010 to 23.6% in 2011–2014) (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.085) (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>A). The contribution of ESBL to the MDR <span class="elsevierStyleItalic">K. pneumoniae</span> isolated in hospitalized patients was 66.8% (4 out of 6) in 2007–2010; this percentage rose to 82.6% (19 out of 23) in 2011–2014 (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.77). The increase observed in non-hospitalized patients between the same periods was 51% (4 out of 8) in 2007–2010 to 74.6% (50 out of 67) in 2011–2014 (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.143) (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>B). The results indicate that the contribution of ESBL to the MDR behaviour was more pronounced in <span class="elsevierStyleItalic">K. pneumoniae</span> isolates. <a class="elsevierStyleCrossRefs" href="#tbl0015">Table 2</a> shows an analysis for linear trend in MDR <span class="elsevierStyleItalic">E. coli</span> and <span class="elsevierStyleItalic">K. pneumoniae</span> in hospitalized patients (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 2A</a>) and MDR <span class="elsevierStyleItalic">E. coli</span> and <span class="elsevierStyleItalic">K. pneumoniae</span> in non-hospitalized patients (<a class="elsevierStyleCrossRef" href="#tbl0020">Table 2B</a>) over the period of the study.</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Susceptibility to other antibiotics in MDR isolates</span><p id="par0105" class="elsevierStylePara elsevierViewall">In order to study the role of alternative antibiotic treatments in the MDR isolates, susceptibility to fosfomycin, meropenem and amoxicillin/clavulanate was analyzed. All the MDR <span class="elsevierStyleItalic">E. coli</span> isolates (from both, inpatients and outpatients) were sensitive to fosfomycin during the first 8 years (first and second periods). The proportion of susceptible isolates diminished during the last period (82% from inpatients and 86% from outpatients).</p><p id="par0110" class="elsevierStylePara elsevierViewall">In the same way, all the isolates studied were susceptible to meropenem (except one isolate of MDR <span class="elsevierStyleItalic">K. pneumoniae</span> from a hospitalized patient harbouring a carbapenemase OXA-48 in 2013).</p><p id="par0115" class="elsevierStylePara elsevierViewall">Susceptibility to amoxicillin/clavulanate decreased along the period of the study in both, MDR <span class="elsevierStyleItalic">E. coli</span> and MDR <span class="elsevierStyleItalic">K. pneumoniae</span>. Susceptibility to amoxicillin/clavulanate in MDR <span class="elsevierStyleItalic">E. coli</span> isolates from hospitalized patients decreased from 84.5% in the period 2003–2006 to 46.8% in the period 2011–2014 (1.8-fold decreased). Comparable results were obtained in the same period when outpatient population was analyzed: 86.6% <span class="elsevierStyleItalic">versus</span> 51.7% respectively. Susceptibility to amoxicillin/clavulanate in MDR <span class="elsevierStyleItalic">K. pneumoniae</span> suffered a more drastic change between 2003–2006 and 2011–2014. All the MDR <span class="elsevierStyleItalic">K. pneumoniae</span> isolates from hospitalized patients were resistant to amoxicillin/clavulanate in 2011–2014 respect to the first period (49.6% were susceptible). Susceptibility to amoxicillin/clavulanate in MDR <span class="elsevierStyleItalic">K. pneumoniae</span> isolates from outpatients decreased from 100% in the period 2003–2006 to 16.4% in the period 2011–2014 (6-fold decrease).</p></span></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Discussion</span><p id="par0120" class="elsevierStylePara elsevierViewall">The increase of bacterial resistance to antibiotics is a cause of global concern. Infections caused by multiresistant microorganisms frequently fail to respond to a suitable empirical therapy and often times, do not achieve treatment success.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">13</span></a></p><p id="par0125" class="elsevierStylePara elsevierViewall">Few studies have reported on the MDR patterns expressed by Gram negative uropathogens in both, hospitalized and non-hospitalized patients, and the evolution over time of such patterns.<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">7,14–16</span></a> Some studies performed at community level have showed a high percentage (about 38%) of MDR in <span class="elsevierStyleItalic">E. coli</span>, the most prevalent bacteria involved in the community-acquired UTI<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">17</span></a> while, on the other hand, MDR-<span class="elsevierStyleItalic">Klebsiella</span> species are considered as one of the most common bacteria involved in nosocomial and urinary tract infections.<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">18</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">The goal of this work was to analyze the evolution of multidrug resistance in both, outpatients and inpatients, to antibiotics commonly used in the treatment of urinary tract infection over a 12-year period. As expected, MDR phenotypes were more usually associated with hospitalization, but the results show that MDR bacteria at the community level are increasing almost at the same rate as in hospitalized patients.</p><p id="par0135" class="elsevierStylePara elsevierViewall">The multiresistance could be associated with the high prescription of these antibiotics groups at community level in Spain.<a class="elsevierStyleCrossRefs" href="#bib0245"><span class="elsevierStyleSup">19,20</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">Quinolone resistance is frequently associated with ESBL-production, and according to the literature, CTX-M represent the most common ESBL produced among bacteria implicated in community-acquired UTI worldwide.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">21</span></a> In our study, a high percentage of strains producing ESBL were detected in MDR isolates from both inpatients and outpatients. The prevalence of infection due to MDR ESBL-producing <span class="elsevierStyleItalic">K. pneumoniae</span> in non-hospitalized patients increased significantly during the last 8 years. On the other hand, exposure to penicillins and/or trimethoprim–sulfamethoxazole has been considered a risk factor for ESBL-producing <span class="elsevierStyleItalic">E. coli</span> isolation.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">22</span></a> All of these results are in accordance with the results obtained in our study suggesting that resistance to quinolones and trimethoprim–sulphamethoxazole are associated with ESBL production. By contrast, this phenomenon was less marked in hospitalized patients.</p><p id="par0145" class="elsevierStylePara elsevierViewall">It is important to take into account that alternative therapies such as fosfomycin represent a promising treatment option against MDR urinary isolates. Fosfomycin resistance is usually rare in areas with limited use but it is increasing in countries with higher usage.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">23</span></a> Our results show that all the MDR <span class="elsevierStyleItalic">E. coli</span> isolates were sensitive to fosfomycin during the first 8 years, but resistant isolates have emerged during the last years. By contrast all the MDR isolates were susceptible to carbapenems due to the absence of carbapenemases.</p><p id="par0150" class="elsevierStylePara elsevierViewall">The emergence and spread of different clones have to be taken into account in order to explain the increase in MDR bacteria. Numerous articles have reported that the well-known high-risk <span class="elsevierStyleItalic">E. coli</span> ST131 and <span class="elsevierStyleItalic">K. pneumoniae</span> ST258 clones have been responsible for the sudden increase in multidrug resistance.<a class="elsevierStyleCrossRefs" href="#bib0270"><span class="elsevierStyleSup">24–27</span></a> ST131 is responsible of UTI, frequently fluoroquinolone resistant and can be linked with the production of CTX-M-15,<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">28</span></a> while ST258 is also known to cause UTI, respiratory tract infections, and blood stream infections and is associated with carbapenemase production, most often KPC-2 and KPC-3.<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">29</span></a> Unfortunately, we do not have information about molecular characterization of the strains isolated in our study.</p><p id="par0155" class="elsevierStylePara elsevierViewall">It is also important to take into consideration that mobile elements (plasmids, transposons, integrons, etc.) play an important role in the transfer of other resistance genes and thus allowing a co-selection phenomenon (see for a review<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">30</span></a>).</p><p id="par0160" class="elsevierStylePara elsevierViewall">The present study has some limitations; it was conducted in an area (Getafe), which represents a small portion of the total population of Spain and, in this case, the results cannot be extrapolated to other settings because specific epidemiology of different areas have to be taken into consideration. Further studies would be necessary to address the problem at national and global level. Despite the above limitations, some strengths are also remarkable and include data of a large sample size of urinary strains isolated over a 12 year period that demonstrates that MDR is an increasing phenomenon of particular importance over the last few years.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Funding</span><p id="par0165" class="elsevierStylePara elsevierViewall">No specific funding has been received.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conflict of interest</span><p id="par0170" class="elsevierStylePara elsevierViewall">None to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:3 [ "identificador" => "xres838138" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec833876" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres838139" "titulo" => "Resumen" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec833877" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Methods" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Study population and bacterial isolates" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Statistical analysis" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Antimicrobial susceptibility" ] ] ] 6 => array:3 [ "identificador" => "sec0030" "titulo" => "Results" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0035" "titulo" => "Prevalence and evolution of MDR profiles" ] 1 => array:2 [ "identificador" => "sec0040" "titulo" => "ESBL contribution to the MDR profile" ] 2 => array:2 [ "identificador" => "sec0045" "titulo" => "Susceptibility to other antibiotics in MDR isolates" ] ] ] 7 => array:2 [ "identificador" => "sec0050" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0055" "titulo" => "Funding" ] 9 => array:2 [ "identificador" => "sec0060" "titulo" => "Conflict of interest" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-10-30" "fechaAceptado" => "2016-02-20" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec833876" "palabras" => array:4 [ 0 => "Multidrug resistance" 1 => "Uropathogens" 2 => "<span class="elsevierStyleItalic">Escherichia coli</span>" 3 => "<span class="elsevierStyleItalic">Klebsiella pneumoniae</span>" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec833877" "palabras" => array:4 [ 0 => "Multirresistencia a antibióticos" 1 => "Uropatógenos" 2 => "<span class="elsevierStyleItalic">Escherichia coli</span>" 3 => "<span class="elsevierStyleItalic">Klebsiella pneumoniae</span>" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The aim of this study was to identify multi-drug resistance (MDR) in the main enterobacteriaceae implicated in urinary tract infections (<span class="elsevierStyleItalic">Escherichia coli</span> and <span class="elsevierStyleItalic">Klebsiella pneumoniae</span>) from both, community and hospitalized patients and to analyze the evolution over a 12-year period.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Microb Dynamic software was used to analyze the microbiology laboratory database and a chi square test was applied to compare differences in group proportions and to determine the linear trend over 12 years in three different periods: 2003–2006, 2007–2010, 2011–2014. We chose amoxicillin, gentamicin, ciprofloxacin and trimethoprim–sulphamethoxazole as MDR markers.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">A total of 39,980 positive urine samples were analyzed, 34,564 (3786 from hospitalized patients and 30,778 from non-hospitalized patients) <span class="elsevierStyleItalic">E. coli</span> isolates, and 5,422 (774 from hospitalized patients and 4,648 from non-hospitalized patients) <span class="elsevierStyleItalic">K. pneumoniae</span> isolates. The prevalence of UTI due to MDR <span class="elsevierStyleItalic">E. coli</span> and MDR <span class="elsevierStyleItalic">K. pneumoniae</span> significantly increased in the period studied, both in hospitalized and outpatients. A higher percentage of MDR <span class="elsevierStyleItalic">E. coli</span> (5.89% in 2007–2010 <span class="elsevierStyleItalic">versus</span> 8.18% in 2011–2014) and MDR <span class="elsevierStyleItalic">K. pneumoniae</span> (2.38% in 2007–2010 <span class="elsevierStyleItalic">versus</span> 9.35% in 2011–2014) was evident and maintained constant over time in hospitalized patients in comparison to non-hospitalized ones. Infection due to MDR ESBL-producing <span class="elsevierStyleItalic">E. coli</span> and <span class="elsevierStyleItalic">K. pneumoniae</span> increased significantly during the last 8 years in both, hospitalized (20% <span class="elsevierStyleItalic">versus</span> 38% and 66.8% <span class="elsevierStyleItalic">versus</span> 82.6%, respectively) and non-hospitalized patients (18.2% <span class="elsevierStyleItalic">versus</span> 23.6% and 51% <span class="elsevierStyleItalic">versus</span> 74.6%, respectively).</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">This study includes data of a large sample size of urinary strains isolated over a 12 year period and demonstrates that MDR is an increasing phenomenon of particular importance in the main UTI-causing species.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introducción</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">El objetivo principal de este estudio fue identificar multirresistencia a antibióticos (<span class="elsevierStyleItalic">multi-drug resistance</span> [MDR]) en las principales enterobacterias implicadas en infecciones del tracto urinario (ITU) (<span class="elsevierStyleItalic">Escherichia coli</span> y <span class="elsevierStyleItalic">Klebsiella pneumoniae</span>) procedentes de pacientes hospitalizados y ambulatorios, y analizar su evolución durante un periodo de 12<span class="elsevierStyleHsp" style=""></span>años.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Métodos</span><p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Se eligieron como marcadores de MDR amoxicilina, gentamicina, ciprofloxacino y trimetoprim-sulfametoxazol. Se realizó un tratamiento estadístico por chi cuadrado de los resultados obtenidos de nuestra base de datos y se analizó la tendencia lineal de la MDR en 3 periodos de 4 años: 2003-2006, 2007-2010 y 2011-2014.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Se analizaron un total de 39.980 muestras de orina con cultivo positivo para <span class="elsevierStyleItalic">E.</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">coli</span> (3.786 de pacientes hospitalizados y 30.778 de pacientes ambulatorios) y 5.422 con cultivo positivo para <span class="elsevierStyleItalic">K.</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">pneumoniae</span> (774 de pacientes hospitalizados y 4.648 de pacientes ambulatorios). La prevalencia de ITU debida a MDR <span class="elsevierStyleItalic">E.</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">coli</span> y MDR <span class="elsevierStyleItalic">K.</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">pneumoniae</span> aumentó significativamente en el periodo estudiado, tanto en pacientes hospitalizados como en pacientes ambulatorios, observándose un mayor porcentaje de MDR <span class="elsevierStyleItalic">E.</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">coli</span> (5,89% en 2007-2010 <span class="elsevierStyleItalic">versus</span> 8,18% en 2011-2014) y MDR <span class="elsevierStyleItalic">K.</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">pneumoniae</span> (2,38% in 2007-2010 <span class="elsevierStyleItalic">versus</span> 9,35% en 2011-2014) en pacientes hospitalizados. La infección debida a MDR <span class="elsevierStyleItalic">E.</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">coli</span> y <span class="elsevierStyleItalic">K.</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">pneumoniae</span> productoras de β-lactamasas de espectro extendido (BLEA) aumentó también de forma significativa durante los últimos 8<span class="elsevierStyleHsp" style=""></span>años, tanto en pacientes hospitalizados (20% <span class="elsevierStyleItalic">versus</span> 38% y 66,8% <span class="elsevierStyleItalic">versus</span> 82,6%, respectivamente) como en los no hospitalizados (18,2% <span class="elsevierStyleItalic">versus</span> 23,6% y 51% <span class="elsevierStyleItalic">versus</span> 74,6%, respectivamente).</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusiones</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">En este estudio se demuestra que la MDR es un fenómeno en aumento de particular importancia en las principales enterobacterias implicadas en ITU.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introducción" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusiones" ] ] ] ] "multimedia" => array:7 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1828 "Ancho" => 1722 "Tamanyo" => 204549 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Prevalence and evolution of MDR <span class="elsevierStyleItalic">E. coli</span> (A) and <span class="elsevierStyleItalic">K. pneumoniae</span> (B) urinary isolates from both, community and hospitalized patients.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1682 "Ancho" => 2792 "Tamanyo" => 336619 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Prevalence and evolution of <span class="elsevierStyleItalic">E. coli</span> (A) and <span class="elsevierStyleItalic">K. pneumoniae</span> (B) urinary isolates from both, community and hospitalized patients, in individual resistance to amoxicillin, ciprofloxacin, gentamicin and trimethoprim–sulphamethoxazole.</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 2180 "Ancho" => 1539 "Tamanyo" => 183601 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">ESBL contribution to the MDR profile in <span class="elsevierStyleItalic">E. coli</span> (A) and <span class="elsevierStyleItalic">K. pneumoniae</span> (B) from both, community and hospitalized patients.</p>" ] ] 3 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1A" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table 1" "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hospitalized patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2003–2006 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2007–2010 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2011–2014 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">χ</span><span class="elsevierStyleSup">2</span> for trend (<span class="elsevierStyleItalic">p</span>) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ESBL-producing <span class="elsevierStyleItalic">E. coli</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.15% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">12.21% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">10.35% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.88 (0.027) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ESBL-producing <span class="elsevierStyleItalic">K. pneumoniae</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6.16% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7.54% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15.04% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">11.19 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1414616.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Percentage of global ESBL-producing <span class="elsevierStyleItalic">E. coli</span> (A) and <span class="elsevierStyleItalic">K. pneumoniae</span> (B) urinary isolates from both, hospitalized patients and outpatients over the periods of the study (2003–2006, 2007–2010, and 2011–2013), and chi square test for trend. A <span class="elsevierStyleItalic">p</span>-value<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 was considered as statistically significant.</p>" ] ] 4 => array:6 [ "identificador" => "tbl0010" "etiqueta" => "Table 1B" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Outpatients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2003–2006 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2007–2010 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2011–2014 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">χ</span><span class="elsevierStyleSup">2</span> for trend (<span class="elsevierStyleItalic">p)</span> \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ESBL-producing <span class="elsevierStyleItalic">E. coli</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.75% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.29% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.69% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">100.03 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ESBL-producing <span class="elsevierStyleItalic">K. pneumoniae</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.18% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.60% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.52% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">51.86 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1414619.png" ] ] ] ] ] 5 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 2A" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table 2" "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Hospitalized patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2003–2006 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2007–2010 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2011–2014 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">χ</span><span class="elsevierStyleSup">2</span> for trend (<span class="elsevierStyleItalic">p</span>) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">MDR <span class="elsevierStyleItalic">E. coli</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.58% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.89% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8.18% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5.99 (<0.014) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">MDR <span class="elsevierStyleItalic">K. pneumoniae</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.45% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.38% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9.35% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">18.38 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">MDR ESBL-producing <span class="elsevierStyleItalic">E. coli</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.86% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.18% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.11% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">17.65 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">MDR ESBL-producing <span class="elsevierStyleItalic">K. pneumoniae</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.09% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.59% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7.72% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">16.10 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1414618.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Percentage of MDR <span class="elsevierStyleItalic">E. coli</span> (A) and <span class="elsevierStyleItalic">K. pneumoniae</span> (B) urinary isolates from both, hospitalized patients and outpatients over the periods of the study (2003–2006, 2007–2010, and 2011–2013), and chi square test for trend. A <span class="elsevierStyleItalic">p</span>-value<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 was considered as statistically significant.</p>" ] ] 6 => array:6 [ "identificador" => "tbl0020" "etiqueta" => "Table 2B" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Outpatients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2003–2006 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2007–2010 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2011–2014 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">χ</span><span class="elsevierStyleSup">2</span> for trend (<span class="elsevierStyleItalic">p</span>) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">MDR <span class="elsevierStyleItalic">E. coli</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.21% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.13% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4.58% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">26.74 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">MDR <span class="elsevierStyleItalic">K. pneumoniae</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.08% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.47% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.78% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">67.27 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">MDR ESBL-producing <span class="elsevierStyleItalic">E. coli</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.18% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.57% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1.08% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">67.07 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">MDR ESBL-producing <span class="elsevierStyleItalic">K. pneumoniae</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.17% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.24% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.82% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">47.54 (<0.001) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1414617.png" ] ] ] ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:30 [ 0 => array:3 [ "identificador" => "bib0155" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antibiotic susceptibility of common pediatric uropathogens in the United States" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "P.D. Tamma" 1 => "D.J. Sklansky" 2 => "D.L. Palazzi" 3 => "S.K. Swami" 4 => "A.M. Milstone" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/cid/ciu360" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2014" "volumen" => "59" "paginaInicial" => "750" "paginaFinal" => "752" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24825869" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0160" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G.S. Tansarli" 1 => "S. Athanasiou" 2 => "M.E. Falagas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/AAC.00359-13" "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "2013" "volumen" => "57" "paginaInicial" => "3628" "paginaFinal" => "3639" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23689709" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0165" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G.C. Schito" 1 => "K.G. Naber" 2 => "H. Botto" 3 => "J. Palou" 4 => "T. Mazzei" 5 => "L. Gualco" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijantimicag.2009.04.012" "Revista" => array:6 [ "tituloSerie" => "Int J Antimicrob Agents" "fecha" => "2009" "volumen" => "34" "paginaInicial" => "407" "paginaFinal" => "413" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19505803" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0170" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Sorlozano" 1 => "A. Jimenez-Pacheco" 2 => "J. de Dios Luna Del Castillo" 3 => "A. Sampedro" 4 => "A. Martinez-Brocal" 5 => "C. Miranda-Casas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ajic.2014.06.013" "Revista" => array:6 [ "tituloSerie" => "Am J Infect Control" "fecha" => "2014" "volumen" => "42" "paginaInicial" => "1033" "paginaFinal" => "1038" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25278389" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0175" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Population structure of <span class="elsevierStyleItalic">Klebsiella pneumoniae</span> causing bloodstream infections at a New York City Tertiary Care Hospital: diversification of multidrug-resistant isolates" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Gomez-Simmonds" 1 => "M. Greenman" 2 => "S.B. Sullivan" 3 => "J.P. Tanner" 4 => "M.G. Sowash" 5 => "S. Whittier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/JCM.03455-14" "Revista" => array:6 [ "tituloSerie" => "J Clin Microbiol" "fecha" => "2015" "volumen" => "53" "paginaInicial" => "2060" "paginaFinal" => "2067" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25878348" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0180" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Occurrence of multidrug resistance to oral antibiotics among <span class="elsevierStyleItalic">Escherichia coli</span> urine isolates from outpatient departments in Germany: extended-spectrum beta-lactamases and the role of fosfomycin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Kresken" 1 => "Y. Pfeifer" 2 => "D. Hafner" 3 => "R. Wresch" 4 => "B. Korber-Irrgang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijantimicag.2014.05.020" "Revista" => array:6 [ "tituloSerie" => "Int J Antimicrob Agents" "fecha" => "2014" "volumen" => "44" "paginaInicial" => "295" "paginaFinal" => "300" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25223936" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0185" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary <span class="elsevierStyleItalic">Escherichia coli</span> from US outpatients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "G.V. Sanchez" 1 => "A.M. Baird" 2 => "J.A. Karlowsky" 3 => "R.N. Master" 4 => "J.M. Bordon" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dku282" "Revista" => array:6 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2014" "volumen" => "69" "paginaInicial" => "3259" "paginaFinal" => "3262" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25063776" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0190" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.P. Magiorakos" 1 => "A. Srinivasan" 2 => "R.B. Carey" 3 => "Y. Carmeli" 4 => "M.E. Falagas" 5 => "C.G. Giske" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1469-0691.2011.03570.x" "Revista" => array:6 [ "tituloSerie" => "Clin Microbiol Infect" "fecha" => "2012" "volumen" => "18" "paginaInicial" => "268" "paginaFinal" => "281" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21793988" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0195" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nosocomial urinary tract infections: a review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "V. Iacovelli" 1 => "G. Gaziev" 2 => "L. Topazio" 3 => "P. Bove" 4 => "G. Vespasiani" 5 => "E. Finazzi Agro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5301/uro.5000092" "Revista" => array:6 [ "tituloSerie" => "Urologia" "fecha" => "2014" "volumen" => "81" "paginaInicial" => "222" "paginaFinal" => "227" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25451882" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0200" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Gupta" 1 => "T.M. Hooton" 2 => "K.G. Naber" 3 => "B. Wullt" 4 => "R. Colgan" 5 => "L.G. Miller" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/cid/ciq257" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2011" "volumen" => "52" "paginaInicial" => "e103" "paginaFinal" => "e120" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21292654" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0205" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enterobacteriaceae that produce extended-spectrum beta-lactamases and AmpC beta-lactamases in the community: the tip of the iceberg" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.D. Pitout" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Curr Pharm Des" "fecha" => "2013" "volumen" => "19" "paginaInicial" => "257" "paginaFinal" => "263" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22934977" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0210" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.D. Pitout" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2165/11533040-000000000-00000" "Revista" => array:6 [ "tituloSerie" => "Drugs" "fecha" => "2010" "volumen" => "70" "paginaInicial" => "313" "paginaFinal" => "333" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20166768" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0215" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Spellberg" 1 => "R. Guidos" 2 => "D. Gilbert" 3 => "J. Bradley" 4 => "H.W. Boucher" 5 => "W.M. Scheld" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1086/524891" "Revista" => array:6 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2008" "volumen" => "46" "paginaInicial" => "155" "paginaFinal" => "164" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18171244" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0220" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D. Ironmonger" 1 => "O. Edeghere" 2 => "A. Bains" 3 => "R. Loy" 4 => "N. Woodford" 5 => "P.M. Hawkey" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dkv043" "Revista" => array:6 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2015" "volumen" => "70" "paginaInicial" => "1744" "paginaFinal" => "1750" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25733586" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0225" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidence and diversity of antimicrobial multidrug resistance profiles of uropathogenic bacteria" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I. Linhares" 1 => "T. Raposo" 2 => "A. Rodrigues" 3 => "A. Almeida" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1155/2015/354084" "Revista" => array:5 [ "tituloSerie" => "Biomed Res Int" "fecha" => "2015" "volumen" => "2015" "paginaInicial" => "354084" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25834814" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0230" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I. Linhares" 1 => "T. Raposo" 2 => "A. Rodrigues" 3 => "A. Almeida" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1471-2334-13-19" "Revista" => array:5 [ "tituloSerie" => "BMC Infect Dis" "fecha" => "2013" "volumen" => "13" "paginaInicial" => "19" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23327474" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0235" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P. Baral" 1 => "S. Neupane" 2 => "B.P. Marasini" 3 => "K.R. Ghimire" 4 => "B. Lekhak" 5 => "B. Shrestha" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1756-0500-5-38" "Revista" => array:5 [ "tituloSerie" => "BMC Res Notes" "fecha" => "2012" "volumen" => "5" "paginaInicial" => "38" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22260454" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0240" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular characterization of class 1 integrons and gene cassettes in multidrug resistant (MDR) <span class="elsevierStyleItalic">Klebsiella</span> spp. isolated from hospitalized and outpatients in Iran, 2009" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "H. Salimizand" 1 => "F. Shahcheraghi" 2 => "E. Kalantar" 3 => "F. Badmasti" 4 => "S.F. Mousavi" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Iran J Microbiol" "fecha" => "2013" "volumen" => "5" "paginaInicial" => "48" "paginaFinal" => "55" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23466743" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0245" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Adriaenssens" 1 => "S. Coenen" 2 => "A. Versporten" 3 => "A. Muller" 4 => "G. Minalu" 5 => "C. Faes" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dkr453" "Revista" => array:7 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2011" "volumen" => "66" "numero" => "Suppl. 6" "paginaInicial" => "vi3" "paginaFinal" => "vi12" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22096064" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0250" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Campos" 1 => "M. Ferech" 2 => "E. Lazaro" 3 => "F. de Abajo" 4 => "J. Oteo" 5 => "P. Stephens" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dkm248" "Revista" => array:6 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2007" "volumen" => "60" "paginaInicial" => "698" "paginaFinal" => "701" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17616551" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0255" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.D. Pitout" 1 => "P. Nordmann" 2 => "K.B. Laupland" 3 => "L. Poirel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dki166" "Revista" => array:6 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2005" "volumen" => "56" "paginaInicial" => "52" "paginaFinal" => "59" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15917288" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0260" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology and risk factors for isolation of <span class="elsevierStyleItalic">Escherichia coli</span> producing CTX-M-type extended-spectrum beta-lactamase in a large U.S. Medical Center" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Hayakawa" 1 => "S. Gattu" 2 => "D. Marchaim" 3 => "A. Bhargava" 4 => "M. Palla" 5 => "K. Alshabani" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/AAC.02516-12" "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "2013" "volumen" => "57" "paginaInicial" => "4010" "paginaFinal" => "4018" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23752516" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0265" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C.G. Giske" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cmi.2015.05.022" "Revista" => array:6 [ "tituloSerie" => "Clin Microbiol Infect" "fecha" => "2015" "volumen" => "21" "paginaInicial" => "899" "paginaFinal" => "905" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26027916" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0270" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N. Woodford" 1 => "J.F. Turton" 2 => "D.M. Livermore" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1574-6976.2011.00268.x" "Revista" => array:6 [ "tituloSerie" => "FEMS Microbiol Rev" "fecha" => "2011" "volumen" => "35" "paginaInicial" => "736" "paginaFinal" => "755" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21303394" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0275" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular epidemiology of <span class="elsevierStyleItalic">Escherichia coli</span> producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G. Peirano" 1 => "J.D. Pitout" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijantimicag.2009.11.003" "Revista" => array:6 [ "tituloSerie" => "Int J Antimicrob Agents" "fecha" => "2010" "volumen" => "35" "paginaInicial" => "316" "paginaFinal" => "321" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20060273" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0280" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "<span class="elsevierStyleItalic">Escherichia coli</span> O25b-ST131: a pandemic, multiresistant, community-associated strain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B.A. Rogers" 1 => "H.E. Sidjabat" 2 => "D.L. Paterson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dkq415" "Revista" => array:6 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2011" "volumen" => "66" "paginaInicial" => "1" "paginaFinal" => "14" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21081548" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0285" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global dissemination of a multidrug resistant <span class="elsevierStyleItalic">Escherichia coli</span> clone" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N.K. Petty" 1 => "N.L. Ben Zakour" 2 => "M. Stanton-Cook" 3 => "E. Skippington" 4 => "M. Totsika" 5 => "B.M. Forde" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1073/pnas.1322678111" "Revista" => array:6 [ "tituloSerie" => "Proc Natl Acad Sci U S A" "fecha" => "2014" "volumen" => "111" "paginaInicial" => "5694" "paginaFinal" => "5699" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24706808" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0290" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "<span class="elsevierStyleItalic">Escherichia coli</span> ST131, an intriguing clonal group" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.H. Nicolas-Chanoine" 1 => "X. Bertrand" 2 => "J.Y. Madec" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/CMR.00125-13" "Revista" => array:6 [ "tituloSerie" => "Clin Microbiol Rev" "fecha" => "2014" "volumen" => "27" "paginaInicial" => "543" "paginaFinal" => "574" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24982321" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0295" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Carbapenemases in <span class="elsevierStyleItalic">Klebsiella pneumoniae</span> and other Enterobacteriaceae: an evolving crisis of global dimensions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "L.S. Tzouvelekis" 1 => "A. Markogiannakis" 2 => "M. Psichogiou" 3 => "P.T. Tassios" 4 => "G.L. Daikos" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/CMR.05035-11" "Revista" => array:6 [ "tituloSerie" => "Clin Microbiol Rev" "fecha" => "2012" "volumen" => "25" "paginaInicial" => "682" "paginaFinal" => "707" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23034326" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0300" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.J. Mathers" 1 => "G. Peirano" 2 => "J.D. Pitout" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/CMR.00116-14" "Revista" => array:6 [ "tituloSerie" => "Clin Microbiol Rev" "fecha" => "2015" "volumen" => "28" "paginaInicial" => "565" "paginaFinal" => "591" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25926236" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/2529993X/0000003500000005/v1_201705111055/S2529993X17301119/v1_201705111055/en/main.assets" "Apartado" => array:4 [ "identificador" => "63564" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/2529993X/0000003500000005/v1_201705111055/S2529993X17301119/v1_201705111055/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X17301119?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 0 | 4 |
2024 October | 9 | 9 | 18 |
2024 September | 27 | 11 | 38 |
2024 August | 25 | 7 | 32 |
2024 July | 22 | 11 | 33 |
2024 June | 8 | 6 | 14 |
2024 May | 26 | 8 | 34 |
2024 April | 24 | 11 | 35 |
2024 March | 26 | 7 | 33 |
2024 February | 18 | 0 | 18 |
2024 January | 19 | 4 | 23 |
2023 December | 25 | 8 | 33 |
2023 November | 24 | 14 | 38 |
2023 October | 31 | 5 | 36 |
2023 September | 22 | 5 | 27 |
2023 August | 26 | 6 | 32 |
2023 July | 17 | 2 | 19 |
2023 June | 30 | 10 | 40 |
2023 May | 36 | 3 | 39 |
2023 April | 68 | 4 | 72 |
2023 March | 48 | 2 | 50 |
2023 February | 42 | 4 | 46 |
2023 January | 41 | 3 | 44 |
2022 December | 27 | 4 | 31 |
2022 November | 19 | 5 | 24 |
2022 October | 35 | 12 | 47 |
2022 September | 20 | 14 | 34 |
2022 August | 14 | 14 | 28 |
2022 July | 18 | 10 | 28 |
2022 June | 15 | 4 | 19 |
2022 May | 10 | 9 | 19 |
2022 April | 12 | 11 | 23 |
2022 March | 16 | 8 | 24 |
2022 February | 9 | 6 | 15 |
2022 January | 17 | 9 | 26 |
2021 December | 11 | 5 | 16 |
2021 November | 7 | 9 | 16 |
2021 October | 10 | 15 | 25 |
2021 September | 13 | 7 | 20 |
2021 August | 10 | 4 | 14 |
2021 July | 11 | 11 | 22 |
2021 June | 12 | 7 | 19 |
2021 May | 19 | 9 | 28 |
2021 April | 24 | 12 | 36 |
2021 March | 14 | 4 | 18 |
2021 February | 11 | 9 | 20 |
2021 January | 9 | 6 | 15 |
2020 December | 13 | 6 | 19 |
2020 November | 11 | 5 | 16 |
2020 October | 5 | 9 | 14 |
2020 September | 12 | 10 | 22 |
2020 August | 12 | 7 | 19 |
2020 July | 10 | 7 | 17 |
2020 June | 9 | 10 | 19 |
2020 May | 14 | 9 | 23 |
2020 April | 7 | 3 | 10 |
2020 March | 4 | 4 | 8 |
2020 February | 7 | 5 | 12 |
2020 January | 9 | 5 | 14 |
2019 December | 10 | 8 | 18 |
2019 November | 7 | 7 | 14 |
2019 October | 11 | 4 | 15 |
2019 September | 6 | 6 | 12 |
2019 August | 5 | 1 | 6 |
2019 July | 10 | 10 | 20 |
2019 June | 14 | 6 | 20 |
2019 May | 48 | 26 | 74 |
2019 April | 23 | 15 | 38 |
2019 March | 1 | 6 | 7 |
2019 February | 4 | 7 | 11 |
2019 January | 2 | 4 | 6 |
2018 December | 1 | 3 | 4 |
2018 November | 4 | 1 | 5 |
2018 October | 4 | 4 | 8 |
2018 September | 3 | 5 | 8 |
2018 August | 2 | 0 | 2 |
2018 July | 5 | 1 | 6 |
2018 June | 0 | 1 | 1 |
2018 May | 3 | 2 | 5 |
2018 April | 3 | 0 | 3 |
2018 March | 6 | 0 | 6 |
2018 February | 0 | 1 | 1 |
2018 January | 17 | 2 | 19 |
2017 December | 2 | 0 | 2 |
2017 November | 5 | 6 | 11 |
2017 October | 6 | 5 | 11 |